These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37549775)

  • 41. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration.
    Jones AL; Kertesz SG; Hausmann LRM; Mor MK; Suo Y; Pettey WBP; Schaefer JH; Gundlapalli AV; Gordon AJ
    J Subst Abuse Treat; 2020 Jun; 113():107996. PubMed ID: 32359670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buprenorphine in the Treatment of Chronic Pain.
    Rudolf GD
    Phys Med Rehabil Clin N Am; 2020 May; 31(2):195-204. PubMed ID: 32279723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.
    Murray JP; Pucci G; Weyer G; Ari M; Dickson S; Kerins A
    Addict Sci Clin Pract; 2023 Jun; 18(1):38. PubMed ID: 37264449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
    Mannelli P; Peindl KS; Lee T; Bhatia KS; Wu LT
    Curr Drug Abuse Rev; 2012 Mar; 5(1):52-63. PubMed ID: 22280332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.
    Powell VD; Rosenberg JM; Yaganti A; Garpestad C; Lagisetty P; Shannon C; Silveira MJ
    JAMA Netw Open; 2021 Sep; 4(9):e2124152. PubMed ID: 34495339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.
    Godersky ME; Saxon AJ; Merrill JO; Samet JH; Simoni JM; Tsui JI
    Addict Sci Clin Pract; 2019 Mar; 14(1):11. PubMed ID: 30867068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Responsible Opioid Prescribing for Chronic Pain: Interpreting the CDC Guideline, Understanding New Rhode Island Regulations.
    Gordon AL; Snyder AF
    R I Med J (2013); 2017 Oct; 100(10):45-47. PubMed ID: 28968623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients' perspectives about the role of primary healthcare providers in long-term opioid therapy: a qualitative study in Dutch primary care.
    Davies LEM; Koerkamp EAJ; Koster ES; Dalusong KJ; Koch B; Schellekens AF; Heringa M; Bouvy ML
    Br J Gen Pract; 2024 Jul; 74(744):e475-e481. PubMed ID: 38499298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.
    Ching JH; Owens DK; Trafton JA; Goldhaber-Fiebert JD; Salomon JA
    Addiction; 2021 Dec; 116(12):3494-3503. PubMed ID: 33999485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "It's that longitudinal relationship that pays off": A qualitative study of internal medicine residents' perspectives on learning to prescribe buprenorphine.
    Logan AA; Jack HE; Darnton J; Klein JW
    Subst Abus; 2021; 42(4):944-950. PubMed ID: 33797320
    [No Abstract]   [Full Text] [Related]  

  • 53. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering.
    Kosakowski S; Benintendi A; Lagisetty P; Larochelle MR; Bohnert ASB; Bazzi AR
    J Gen Intern Med; 2022 May; 37(7):1722-1728. PubMed ID: 34993861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.
    Leece P; Khorasheh T; Corace K; Strike C; Bayoumi AM; Taha S; Marks E; Pach B; Ahamad K; Grennell E; Holowaty M; Manson H; Straus SE
    BMJ Open; 2019 Dec; 9(12):e032285. PubMed ID: 31843837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic relationships between Veterans and buprenorphine providers and effects on treatment retention.
    Vakkalanka JP; Lund BC; Arndt S; Field W; Charlton M; Ward MM; Carnahan RM
    Health Serv Res; 2022 Apr; 57(2):392-402. PubMed ID: 34854083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia.
    Barnett A; Savic M; Lintzeris N; Bathish R; Arunogiri S; Dunlop AJ; Haber P; Graham R; Hayes V; Lubman DI
    Drug Alcohol Depend; 2021 Oct; 227():108959. PubMed ID: 34450472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report.
    Hathaway DB; Bhat JA; Twark C; Rodriguez C; Suzuki J
    Am J Addict; 2023 Jul; 32(4):410-414. PubMed ID: 36850041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perioperative Buprenorphine Management: A Multidisciplinary Approach.
    Hickey T; Abelleira A; Acampora G; Becker WC; Falker CG; Nazario M; Weimer MB
    Med Clin North Am; 2022 Jan; 106(1):169-185. PubMed ID: 34823729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.